Crossmark

Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2021.10.005

Published Print: 2022-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ay, S.

Efiloğlu, Ö.

Tataroğlu Özyükseler, D.

Dülgar, Ö.

Mutlu Günaydın, U.

Yıldırım, A.

Gümüş, M.
License Information

Text and Data Mining valid from 2022-11-01
More Information

This article is maintained by: Elsevier

Article Title: Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2021.10.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2021.10.003

Content Type: article

Copyright: © 2022 AEU. Published by Elsevier España, S.L.U. All rights reserved.